Is Chemomab Therapeutics Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Chemomab Therapeutics Ltd (CMMB) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Chemomab Therapeutics Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Chemomab Therapeutics Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Chemomab Therapeutics Ltd?

Muslim investors may consider investing in Chemomab Therapeutics Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Chemomab Therapeutics Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Chemomab Therapeutics Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Chemomab Therapeutics Ltd updated?

The Shariah compliance status of Chemomab Therapeutics Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Chemomab Therapeutics Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Chemomab Therapeutics Ltd?

You can check the latest Shariah compliance status of Chemomab Therapeutics Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

CMMB Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 30, 2026

Report Source: 2025 Annual Report

Chemomab Therapeutics Ltd. Stock Analysis CMMB

United States Health Care Nano Cap Report: 2025 Annual

Chemomab Therapeutics Ltd. is a clinical-stage biotech company, which engages in the provision of therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company employs 12 full-time employees The company went IPO on 2012-08-14. The firm specializes in the development of patient oriented targeted therapy for the treatment of a wide range of fibrotic and inflammatory diseases with high unmet medical need among others. Its therapeutic and diagnostic technology, BC-819, constitutes a search paradigm for the targeted destruction of cancer cells with no effect on surrounding tissue and no observed side effects for long-term, safe treatment and prevention of cancer. The patient oriented targeted therapy approach is based on the identification of particular genes that are expressed only in tumors.

Key Statistics of Chemomab Therapeutics Ltd (CMMB)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$1.64$1.73

Today's Open

$1.72

Volume

7528.00

P/E Ratio (TTM)

52 Week Range

$1.35$5.88

Market Cap

11.65M

Avg. Volume

41.18K

Dividend Yield

Financial Metrics & Statements of Chemomab Therapeutics Ltd (CMMB)

FAQ's for Chemomab Therapeutics Ltd (CMMB)

According to Musaffa’s Shariah screening methodology, Chemomab Therapeutics Ltd (CMMB) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.